Loading patent…
AssigneesViktor Veniaminovich Tets, Georgy Viktorovich Tets
InventorsViktor Veniaminovich Tets, Georgy Viktorovich Tets, Konstantin Andreevich Krasnov
Estimating the term…
The invention relates to medicine, namely, to the solutions used for hemostasis. The hemostatic agent, which represents a polyammonia methanediamine chloride of the general formula where: n=1-20, m=1-10, at that n×m≧8. The hemostatic agent may be applied in the form of a 0.01-10% aqueous solution. An aqueous solution of the preparation can be used for impregnation of materials used for bleeding arrest, suture material, bandaging material. The hemostatic agent may be used in the composition of a retraction cord, adhesive pastes, vaginal and rectal suppositories, creams, gels, as well as used with microchips that provide slow release of the preparation. The preparation can also be used in eye drops, eye ointments, and lubricants applied to the surface of the catheter. The drug can be used in endodontic treatment, may be injected into a polymer sealer for root canal obturation, as well as locally—by means of electrophoresis. The hemostatic agent may be used in conjunction with a gel based on aluminum sulphate or silver solution, and also with a polysaccharide haemostatic system. An efficient haemostatic preparation ensuring a significant analgetic effect is developed.
A hemostatic agent, which represents a polyammonia methanediamine chloride of the general formula
A hemostatic agent as per Par. 1, which differs in the fact that it is applied in the form of a 0.01-10% aqueous solution.
A hemostatic agent as per Par. 2, which differs in the fact that it is used for impregnation of hemostatic materials.
A hemostatic agent as per Par. 3, which differs in the fact that it is used for impregnation of suture materials.
A hemostatic agent as per Par. 3, which differs in the fact that it is used for impregnation of bandaging materials.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of a retraction cord.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of adhesive pastes.
A hemostatic agent as per Par. 2, which differs in the fact that it is used in the form of a spray.
A hemostatic agent as per Par. 2, which differs in the fact that it is used for inhalation.
A hemostatic agent as per Par. 1, which differs in the fact that it is used in the form of vaginal suppositories.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of rectal suppositories.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of a cream.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of a gel.
A hemostatic agent as per Par. 1, which differs in the fact that it is applied using chips that provide slow release of the drug.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of eye drops.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of eye ointments.
A hemostatic agent as per Par. 1, which differs in the fact that it is used as part of a lubricant applied onto the surface of the catheter.
A hemostatic agent as per Par. 1, which differs in the fact that it is used for endodontic treatment.
A hemostatic agent as per Par. 1, which differs in the fact that it is introduced into a polymer sealer for root canal obturation.
A hemostatic agent as per Par. 1, which differs in the fact that it is administered locally by means of electrophoresis.
A hemostatic agent as per Par. 1, which differs in the fact that it is used in conjunction with a gel based on aluminum sulphate or a silver nitrate solution.
A hemostatic agent as per Par. 1, which differs in the fact that it is used in conjunction with a polysaccharide hemostatic system.
Dependencies are inferred from the claim text.